Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Correction: Calcium electroporation for treatment of sarcoma in preclinical studies

    Research output: Contribution to journalJournal articleResearch

  2. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Real-world evidence to guide healthcare policies in oncology

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Orbital precursor B-lymphoblastic lymphoma involving the extraocular muscles in a 56-year-old male and a review of the literature

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Suction blister lesions and epithelialization monitored by optical coherence tomography

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Lymphotoxin α (LTα) plays a key role in the formation of lymphatic vasculature and secondary lymphoid structures. Cutaneous T cell lymphoma (CTCL) is the most common primary lymphoma of the skin and in advanced stages, malignant T cells spreads through the lymphatic to regional lymph nodes to internal organs and blood. Yet, little is known about the mechanism of the CTCL dissemination. Here, we show that CTCL cells express LTα in situ and that LTα expression is driven by aberrantly activated JAK3/STAT5 pathway. Importantly, via TNF receptor 2, LTα functions as an autocrine factor by stimulating expression of IL-6 in the malignant cells. LTα and IL-6, together with VEGF promote angiogenesis by inducing endothelial cell sprouting and tube formation. Thus, we propose that LTα plays a role in malignant angiogenesis and disease progression in CTCL and may serve as a therapeutic target in this disease.

Original languageEnglish
JournalOncotarget
Volume6
Issue number17
Pages (from-to)15235-49
Number of pages15
ISSN1949-2553
Publication statusPublished - 20 Jun 2015

Bibliographical note

Lauenborg B1, Christensen L1, Ralfkiaer U2, Kopp KL1, Jønson L3, Dabelsteen S4, Bonefeld CM1, Geisler C1, Gjerdrum LM5, Zhang Q6, Wasik MA6, Ralfkiaer E7, Ødum N1, Woetmann A1.
Author information
1Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
2Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark.
3Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark.
4Department of Oral Medicine and Pathology, School of Dentistry, University of Copenhagen, Copenhagen, Denmark.
5Department of Pathology, Roskilde Hospital, Roskilde, Denmark.
6Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
7Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark.

ID: 45731609